The IndiTreat® tests measure the sensitivity of a particular patient’s tumoroids to a specific panel of cancer treatments and compares it to a reference population of tumoroids from patients treated with the same drugs.

The results are categorized from “Low Sensitivity” to “High Sensitivity” and positioned in a reference graph. The IndiTreat® results are summarized in a table (figure 1.) showing the sensitivity profile of the patient tumor to each drug. The available drug panels are shown in (figure 2.).